Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Association between maternal periconceptional alcohol consumption and neural tube defects: Findings from the National Birth Defects Prevention Study, 1997-2011.

Louden AR, Suhl J, Kancherla V, Caspers Conway KM, Makelarski J, Howley MM, Hoyt AT, Olney RS, Olshan AF, Romitti PA; National Birth Defects Prevention Study.

Birth Defects Res. 2020 Mar;112(5):427-439. doi: 10.1002/bdr2.1656. Epub 2020 Feb 27.

PMID:
32104984
2.

Population-Based Surveillance for Birth Defects Potentially Related to Zika Virus Infection - 22 States and Territories, January 2016-June 2017.

Smoots AN, Olson SM, Cragan J, Delaney A, Roth NM, Godfred-Cato S, Jones AM, Nahabedian JF 3rd, Fornoff J, Sandidge T, Yazdy MM, Higgins C, Olney RS, Eckert V, Forkner A, Fox DJ, Stolz A, Crawford K, Cho SJ, Knapp M, Ahmed MF, Lake-Burger H, Elmore AL, Langlois P, Breidenbach R, Nance A, Denson L, Caton L, Forestieri N, Bergman K, Humphries BK, Leedom VO, Tran T, Johnston J, Valencia-Prado M, Pérez-González S, Romitti PA, Fall C, Bryan JM, Barton J, Arias W, St John K, Mann S, Kimura J, Orantes L, Martin B, de Wilde L, Ellis EM, Song Z, Akosa A, Goodroe C, Ellington SR, Tong VT, Gilboa SM, Moore CA, Honein MA.

MMWR Morb Mortal Wkly Rep. 2020 Jan 24;69(3):67-71. doi: 10.15585/mmwr.mm6903a3.

3.

Maternal report of fever from cold or flu during early pregnancy and the risk for noncardiac birth defects, National Birth Defects Prevention Study, 1997-2011.

Waller DK, Hashmi SS, Hoyt AT, Duong HT, Tinker SC, Gallaway MS, Olney RS, Finnell RH, Hecht JT, Canfield MA; National Birth Defects Prevention Study.

Birth Defects Res. 2018 Mar 1;110(4):342-351. doi: 10.1002/bdr2.1147. Epub 2017 Nov 2.

4.

Development and implementation of the first national data quality standards for population-based birth defects surveillance programs in the United States.

Anderka M, Mai CT, Romitti PA, Copeland G, Isenburg J, Feldkamp ML, Krikov S, Rickard R, Olney RS, Canfield MA, Stanton C, Mosley B, Kirby RS.

BMC Public Health. 2015 Sep 19;15:925. doi: 10.1186/s12889-015-2223-2.

5.

State Legislation, Regulations, and Hospital Guidelines for Newborn Screening for Critical Congenital Heart Defects - United States, 2011-2014.

Glidewell J, Olney RS, Hinton C, Pawelski J, Sontag M, Wood T, Kucik JE, Daskalov R, Hudson J; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):625-30.

6.

Detection of critical congenital heart defects: Review of contributions from prenatal and newborn screening.

Olney RS, Ailes EC, Sontag MK.

Semin Perinatol. 2015 Apr;39(3):230-7. doi: 10.1053/j.semperi.2015.03.007. Review.

7.

Next steps for birth defects research and prevention: The birth defects study to evaluate pregnancy exposures (BD-STEPS).

Tinker SC, Carmichael SL, Anderka M, Browne ML, Caspers Conway KM, Meyer RE, Nembhard WN, Olney RS, Reefhuis J; Birth Defects Study To Evaluate Pregnancy exposureS.

Birth Defects Res A Clin Mol Teratol. 2015 Aug;103(8):733-40. doi: 10.1002/bdra.23373. Epub 2015 Apr 6.

8.

Factors associated with high hospital resource use in a population-based study of children with orofacial clefts.

Razzaghi H, Dawson A, Grosse SD, Allori AC, Kirby RS, Olney RS, Correia J, Cassell CH.

Birth Defects Res A Clin Mol Teratol. 2015 Feb;103(2):127-43. doi: 10.1002/bdra.23356.

9.

Birth defects data from population-based birth defects surveillance programs in the United States, 2007 to 2011: highlighting orofacial clefts.

Mai CT, Cassell CH, Meyer RE, Isenburg J, Canfield MA, Rickard R, Olney RS, Stallings EB, Beck M, Hashmi SS, Cho SJ, Kirby RS; National Birth Defects Prevention Network.

Birth Defects Res A Clin Mol Teratol. 2014 Nov;100(11):895-904. doi: 10.1002/bdra.23329. Epub 2014 Nov 14.

10.

Differences in risk factors for second and third degree hypospadias in the national birth defects prevention study.

Woud SG, van Rooij IA, van Gelder MM, Olney RS, Carmichael SL, Roeleveld N, Reefhuis J; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2014 Sep;100(9):703-11. doi: 10.1002/bdra.23296. Epub 2014 Sep 2.

11.

Maternal periconceptional alcohol consumption and congenital limb deficiencies.

Caspers Conway KM, Romitti PA, Holmes L, Olney RS, Richardson SD; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2014 Nov;100(11):863-76. doi: 10.1002/bdra.23292. Epub 2014 Aug 18.

12.

Hospitalizations and associated costs in a population-based study of children with Down syndrome born in Florida.

Dawson AL, Cassell CH, Oster ME, Olney RS, Tanner JP, Kirby RS, Correia J, Grosse SD.

Birth Defects Res A Clin Mol Teratol. 2014 Nov;100(11):826-36. doi: 10.1002/bdra.23295. Epub 2014 Aug 13.

13.

Maternal periconceptional occupational pesticide exposure and neural tube defects.

Makelarski JA, Romitti PA, Rocheleau CM, Burns TL, Stewart PA, Waters MA, Lawson CC, Bell EM, Lin S, Shaw GM, Olney RS; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2014 Nov;100(11):877-86. doi: 10.1002/bdra.23293. Epub 2014 Aug 15.

14.

The association between race/ethnicity and major birth defects in the United States, 1999-2007.

Canfield MA, Mai CT, Wang Y, O'Halloran A, Marengo LK, Olney RS, Borger CL, Rutkowski R, Fornoff J, Irwin N, Copeland G, Flood TJ, Meyer RE, Rickard R, Alverson CJ, Sweatlock J, Kirby RS; National Birth Defects Prevention Network.

Am J Public Health. 2014 Sep;104(9):e14-23. doi: 10.2105/AJPH.2014.302098. Epub 2014 Jul 17.

15.

Descriptive and risk factor analysis for choanal atresia: The National Birth Defects Prevention Study, 1997-2007.

Kancherla V, Romitti PA, Sun L, Carey JC, Burns TL, Siega-Riz AM, Druschel CM, Lin AE, Olney RS; National Birth Defects Prevention Study.

Eur J Med Genet. 2014 Apr;57(5):220-9. doi: 10.1016/j.ejmg.2014.02.010. Epub 2014 Feb 24.

16.

Late detection of critical congenital heart disease among US infants: estimation of the potential impact of proposed universal screening using pulse oximetry.

Peterson C, Ailes E, Riehle-Colarusso T, Oster ME, Olney RS, Cassell CH, Fixler DE, Carmichael SL, Shaw GM, Gilboa SM.

JAMA Pediatr. 2014 Apr;168(4):361-70. doi: 10.1001/jamapediatrics.2013.4779.

17.

A public health economic assessment of hospitals' cost to screen newborns for critical congenital heart disease.

Peterson C, Grosse SD, Glidewell J, Garg LF, Van Naarden Braun K, Knapp MM, Beres LM, Hinton CF, Olney RS, Cassell CH.

Public Health Rep. 2014 Jan-Feb;129(1):86-93.

18.
19.

Self-reported maternal cigarette smoke exposure during the periconceptional period and the risk for omphalocoele.

Feldkamp ML, Srisukhumbowornchai S, Romitti PA, Olney RS, Richardson SD, Botto LD; National Birth Defects Prevention Study.

Paediatr Perinat Epidemiol. 2014 Jan;28(1):67-73. doi: 10.1111/ppe.12093. Epub 2013 Nov 8.

20.

Developing a public health-tracking system for follow-up of newborn screening metabolic conditions: a four-state pilot project structure and initial findings.

Hinton CF, Mai CT, Nabukera SK, Botto LD, Feuchtbaum L, Romitti PA, Wang Y, Piper KN, Olney RS.

Genet Med. 2014 Jun;16(6):484-90. doi: 10.1038/gim.2013.177. Epub 2013 Dec 5.

21.

Frequency of prenatal cytogenetic diagnosis and pregnancy outcomes by maternal race-ethnicity, and the effect on the prevalence of trisomy 21, Metropolitan Atlanta, 1996-2005.

Jackson JM, Crider KS, Cragan JD, Rasmussen SA, Olney RS.

Am J Med Genet A. 2014 Jan;164A(1):70-6. doi: 10.1002/ajmg.a.36247. Epub 2013 Nov 22.

22.

Maternal periconceptional exposure to cigarette smoking and congenital limb deficiencies.

Caspers KM, Romitti PA, Lin S, Olney RS, Holmes LB, Werler MM; National Birth Defects Prevention Study.

Paediatr Perinat Epidemiol. 2013 Nov;27(6):509-20. doi: 10.1111/ppe.12075. Epub 2013 Jul 31.

23.

Selected birth defects data from population-based birth defects surveillance programs in the United States, 2005–2009: Featuring critical congenital heart defects targeted for pulse oximetry screening.

Mai CT, Riehle-Colarusso T, O'Halloran A, Cragan JD, Olney RS, Lin A, Feldkamp M, Botto LD, Rickard R, Anderka M, Ethen M, Stanton C, Ehrhardt J, Canfield M; National Birth Defects Prevention Network.

Birth Defects Res A Clin Mol Teratol. 2012 Dec;94(12):970-83. No abstract available.

24.

Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection?

Peterson C, Dawson A, Grosse SD, Riehle-Colarusso T, Olney RS, Tanner JP, Kirby RS, Correia JA, Watkins SM, Cassell CH.

Birth Defects Res A Clin Mol Teratol. 2013 Oct;97(10):664-72. doi: 10.1002/bdra.23165. Epub 2013 Sep 2.

25.

Factors associated with late detection of critical congenital heart disease in newborns.

Dawson AL, Cassell CH, Riehle-Colarusso T, Grosse SD, Tanner JP, Kirby RS, Watkins SM, Correia JA, Olney RS.

Pediatrics. 2013 Sep;132(3):e604-11. doi: 10.1542/peds.2013-1002. Epub 2013 Aug 12.

26.

Cost-effectiveness of routine screening for critical congenital heart disease in US newborns.

Peterson C, Grosse SD, Oster ME, Olney RS, Cassell CH.

Pediatrics. 2013 Sep;132(3):e595-603. doi: 10.1542/peds.2013-0332. Epub 2013 Aug 5.

27.

Maternal periconceptional occupational exposure to pesticides and selected musculoskeletal birth defects.

Kielb C, Lin S, Herdt-Losavio M, Bell E, Chapman B, Rocheleau CM, Lawson C, Waters M, Stewart P, Olney RS, Romitti PA, Cao Y, Druschel C; National Birth Defects Prevention Study.

Int J Hyg Environ Health. 2014 Mar;217(2-3):248-54. doi: 10.1016/j.ijheh.2013.06.003. Epub 2013 Jun 20.

28.

Results from the New Jersey statewide critical congenital heart defects screening program.

Garg LF, Van Naarden Braun K, Knapp MM, Anderson TM, Koppel RI, Hirsch D, Beres LM, Sweatlock J, Olney RS, Glidewell J, Hinton CF, Kemper AR.

Pediatrics. 2013 Aug;132(2):e314-23. doi: 10.1542/peds.2013-0269. Epub 2013 Jul 15.

29.

Hypospadias and maternal intake of phytoestrogens.

Carmichael SL, Cogswell ME, Ma C, Gonzalez-Feliciano A, Olney RS, Correa A, Shaw GM; National Birth Defects Prevention Study.

Am J Epidemiol. 2013 Aug 1;178(3):434-40. doi: 10.1093/aje/kws591. Epub 2013 Jun 9.

30.

Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997-2007.

Lind JN, Tinker SC, Broussard CS, Reefhuis J, Carmichael SL, Honein MA, Olney RS, Parker SE, Werler MM; National Birth Defects Prevention Study.

Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):783-93. doi: 10.1002/pds.3448. Epub 2013 Apr 26.

31.

Periconceptional maternal alcohol consumption and neural tube defects.

Makelarski JA, Romitti PA, Sun L, Burns TL, Druschel CM, Suarez L, Olshan AF, Siega-Riz AM, Olney RS; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2013 Mar;97(3):152-60. doi: 10.1002/bdra.23122. Epub 2013 Mar 4.

32.

Newborn screening for critical congenital heart disease: essential public health roles for birth defects monitoring programs.

Olney RS, Botto LD.

Birth Defects Res A Clin Mol Teratol. 2012 Dec;94(12):965-9. doi: 10.1002/bdra.23103. Epub 2012 Nov 27. Review.

PMID:
23184496
33.

Maternal caffeine consumption and risk of congenital limb deficiencies.

Chen L, Bell EM, Browne ML, Druschel CM, Romitti PA, Schmidt RJ, Burns TL, Moslehi R, Olney RS; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2012 Dec;94(12):1033-43. doi: 10.1002/bdra.23050. Epub 2012 Aug 18.

34.

Nutritional factors and hypospadias risks.

Carmichael SL, Ma C, Feldkamp ML, Munger RG, Olney RS, Botto LD, Shaw GM, Correa A.

Paediatr Perinat Epidemiol. 2012 Jul;26(4):353-60. doi: 10.1111/j.1365-3016.2012.01272.x. Epub 2012 May 17.

35.

Maternal asthma medication use and the risk of selected birth defects.

Lin S, Munsie JP, Herdt-Losavio ML, Druschel CM, Campbell K, Browne ML, Romitti PA, Olney RS, Bell EM; National Birth Defects Prevention Study.

Pediatrics. 2012 Feb;129(2):e317-24. doi: 10.1542/peds.2010-2660. Epub 2012 Jan 16.

36.

Trends in cytogenetic testing and identification of chromosomal abnormalities among pregnancies and children with birth defects, metropolitan Atlanta, 1968-2005.

Jackson JM, Crider KS, Rasmussen SA, Cragan JD, Olney RS.

Am J Med Genet A. 2012 Jan;158A(1):116-23. doi: 10.1002/ajmg.a.34385. Epub 2011 Dec 2.

PMID:
22140020
37.

Spina bifida subtypes and sub-phenotypes by maternal race/ethnicity in the National Birth Defects Prevention Study.

Agopian AJ, Canfield MA, Olney RS, Lupo PJ, Ramadhani T, Mitchell LE, Shaw GM, Moore CA; National Birth Defects Prevention Study.

Am J Med Genet A. 2012 Jan;158A(1):109-15. doi: 10.1002/ajmg.a.34383. Epub 2011 Dec 2.

PMID:
22140002
38.

Bladder exstrophy: an epidemiologic study from the International Clearinghouse for Birth Defects Surveillance and Research, and an overview of the literature.

Siffel C, Correa A, Amar E, Bakker MK, Bermejo-Sánchez E, Bianca S, Castilla EE, Clementi M, Cocchi G, Csáky-Szunyogh M, Feldkamp ML, Landau D, Leoncini E, Li Z, Lowry RB, Marengo LK, Mastroiacovo P, Morgan M, Mutchinick OM, Pierini A, Rissmann A, Ritvanen A, Scarano G, Szabova E, Olney RS.

Am J Med Genet C Semin Med Genet. 2011 Nov 15;157C(4):321-32. doi: 10.1002/ajmg.c.30316. Epub 2011 Oct 14. Review.

39.

Maternal occupational pesticide exposure and risk of hypospadias in the National Birth Defects Prevention Study.

Rocheleau CM, Romitti PA, Sanderson WT, Sun L, Lawson CC, Waters MA, Stewart PA, Olney RS, Reefhuis J.

Birth Defects Res A Clin Mol Teratol. 2011 Nov;91(11):927-36. doi: 10.1002/bdra.22860. Epub 2011 Sep 22.

40.

Maternal self-reported genital tract infections during pregnancy and the risk of selected birth defects.

Carter TC, Olney RS, Mitchell AA, Romitti PA, Bell EM, Druschel CM; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2011 Feb;91(2):108-16. doi: 10.1002/bdra.20749. Epub 2010 Dec 7.

41.

Population-based surveillance for rare congenital and inherited disorders: models and challenges.

Jackson JM, Crider KS, Olney RS.

Adv Exp Med Biol. 2010;686:133-50. doi: 10.1007/978-90-481-9485-8_9. Review.

PMID:
20824444
42.

Caffeine, selected metabolic gene variants, and risk for neural tube defects.

Schmidt RJ, Romitti PA, Burns TL, Murray JC, Browne ML, Druschel CM, Olney RS; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2010 Jul;88(7):560-9. doi: 10.1002/bdra.20681.

43.

Prevalence of congenital hypothyroidism--current trends and future directions: workshop summary.

Olney RS, Grosse SD, Vogt RF Jr.

Pediatrics. 2010 May;125 Suppl 2:S31-6. doi: 10.1542/peds.2009-1975C.

PMID:
20435715
44.

Health status and healthcare use in a national sample of children with sickle cell disease.

Boulet SL, Yanni EA, Creary MS, Olney RS.

Am J Prev Med. 2010 Apr;38(4 Suppl):S528-35. doi: 10.1016/j.amepre.2010.01.003.

PMID:
20331954
45.

Association of paternal age and risk for major congenital anomalies from the National Birth Defects Prevention Study, 1997 to 2004.

Green RF, Devine O, Crider KS, Olney RS, Archer N, Olshan AF, Shapira SK; National Birth Defects Prevention Study.

Ann Epidemiol. 2010 Mar;20(3):241-9. doi: 10.1016/j.annepidem.2009.10.009. Epub 2010 Jan 6.

46.

Prevalence of developmental disabilities and receipt of special education services among children with an inborn error of metabolism.

Powell K, Van Naarden Braun K, Singh R, Shapira SK, Olney RS, Yeargin-Allsopp M.

J Pediatr. 2010 Mar;156(3):420-6. doi: 10.1016/j.jpeds.2009.09.068. Epub 2009 Nov 14.

PMID:
19914633
47.

Long-term speech and language developmental issues among children with Duarte galactosemia.

Powell KK, Van Naarden Braun K, Singh RH, Shapira SK, Olney RS, Yeargin-Allsopp M.

Genet Med. 2009 Dec;11(12):874-9. doi: 10.1097/GIM.0b013e3181c0c38d.

PMID:
19904210
48.

Maternal caffeine consumption and risk of neural tube defects.

Schmidt RJ, Romitti PA, Burns TL, Browne ML, Druschel CM, Olney RS; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2009 Nov;85(11):879-89. doi: 10.1002/bdra.20624.

49.

Multistate study of the epidemiology of clubfoot.

Parker SE, Mai CT, Strickland MJ, Olney RS, Rickard R, Marengo L, Wang Y, Hashmi SS, Meyer RE; National Birth Defects Prevention Network.

Birth Defects Res A Clin Mol Teratol. 2009 Nov;85(11):897-904. doi: 10.1002/bdra.20625.

PMID:
19697433
50.

Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations.

Caton AR, Bell EM, Druschel CM, Werler MM, Lin AE, Browne ML, McNutt LA, Romitti PA, Mitchell AA, Olney RS, Correa A; National Birth Defects Prevention Study.

Hypertension. 2009 Jul;54(1):63-70. doi: 10.1161/HYPERTENSIONAHA.109.129098. Epub 2009 May 11.

Supplemental Content

Loading ...
Support Center